Medical Oncologist
CION Cancer Clinics
Which chemotherapy regimen for which situation in colon cancer? | CION Cancer Clinics
There is no one regimen that is right for everyone with colon cancer. The choice depends on why chemotherapy is being given, what tests on the tumour show, how fit you are and how treatment fits your life. This page explains how oncologists match the regimen to the situation, so the plan you are offered makes sense. The drug details sit on separate pages. At CION Cancer Clinics, a multidisciplinary team plans colon cancer treatment for your stage, from surgery to chemotherapy and follow-up.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- How do oncologists choose a chemotherapy regimen for colon cancer?
- How is chemotherapy after surgery different from chemotherapy for stage 4?
- Which regimen tends to suit which person?
- What does your oncologist look at before choosing?
- Four beliefs about choosing chemotherapy, and what is true
- What this page cannot tell you
- Common questions about choosing a colon cancer regimen
The short answer
How do oncologists choose a chemotherapy regimen for colon cancer?
They start with one question: why is chemotherapy being given? After surgery for stage II or III, the aim is to lower the chance of the cancer coming back, and the list of choices is short. For cancer that has spread, the aim is control over a longer time, and the tumour's test results shape the plan far more.
After surgery, a short list
Almost everyone is offered one of three things: FOLFOX, CAPOX, or a single drug, fluorouracil or capecitabine, on its own. The real decisions are whether to add oxaliplatin and for how long. Targeted drugs are not added after surgery, because trials found they did not help there. Immunotherapy after surgery is being studied for MSI-high stage III cancer, and your oncologist can tell you where that stands.
For advanced cancer, the tumour decides more
Here the tumour's tests come first. MSI status, RAS and BRAF results, and the side of the colon where the cancer started all decide whether immunotherapy or a targeted drug joins the chemotherapy, or replaces it. That is why the side of the tumour can change the drug choice, and why these tests are done before treatment starts.
This page explains the choice. Schedules, side effects and practical details of each regimen are on the chemotherapy pages.Side by side
How is chemotherapy after surgery different from chemotherapy for stage 4?
After surgery, stage II or III
Cancer that has spread, stage 4
Aim: lower the chance of a return
Aim: shrink or control the cancer
Usually FOLFOX, CAPOX or a single drug
FOLFOX, CAPOX or FOLFIRI, sometimes all three drugs together
A fixed course, often about three or six months
Ongoing, adjusted to how the cancer responds
Targeted drugs are not added
Targeted drugs or immunotherapy often join, guided by tests
Decided mainly by stage and risk features
Decided mainly by tumour tests and fitness
Not sure whether this applies to you?
Ask an oncologistThe main options
Which regimen tends to suit which person?
Each option below is a standard, recognised choice. The names describe the drugs. Which one fits depends on the person.
FOLFOX
Fluorouracil and leucovorin with oxaliplatin, given every two weeks. Part of each round runs through a small pump you carry home, which needs a port or a line in a vein. The FOLFOX regimen page explains each round.
Often chosen when
- Regular day-unit visits are easy to manage
- Tablets would be hard to take reliably
CAPOX, also called XELOX
Capecitabine tablets taken at home, with an oxaliplatin drip every three weeks. Fewer hospital visits, and no pump to carry. The CAPOX regimen page covers the tablet schedule.
Often chosen when
- You live far from the centre, in a district town
- A shorter course is planned
A single drug
Capecitabine or fluorouracil on its own, without oxaliplatin. It is gentler and avoids the lasting numbness oxaliplatin can cause, though the benefit is smaller.
Often chosen for
- High-risk stage II that is not MSI-high
- Older or less fit people
- Existing numbness, for example from diabetes
FOLFIRI and the triplet
In FOLFIRI, irinotecan replaces oxaliplatin. A very fit person may get all three drugs together, as FOLFOXIRI. Both are used for cancer that has spread, and not as routine treatment after surgery.
Often chosen for
- Advanced cancer, first or second treatment
- Shrinking tumours so surgery may become possible
What is weighed
What does your oncologist look at before choosing?
Your stage and risk features
The pathology report gives the stage, the lymph node count and features such as a tumour growing through the bowel wall. These decide whether oxaliplatin is worth adding, and whether three or six months makes more sense.
Your tumour tests
MSI or MMR status, which shows whether the tumour's DNA repair system works, matters at every stage. For advanced cancer, RAS, BRAF and the tumour's side decide which targeted drug or immunotherapy may join the plan.
Your body
Age, kidney and heart function, diabetes and any numbness you already have all count. Some doctors first check for DPD deficiency, an inherited difference that makes fluorouracil and capecitabine hard for the body to clear safely.
Your life
How far you live from the centre, who can bring you, whether you can manage a pump at home and how the cost will be met. Insurance and schemes such as Aarogyasri and Ayushman Bharat pay through set packages, which can shape what is practical.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Four beliefs about choosing chemotherapy, and what is true
"My relative had the same stage, so I should get the same drugs."
Two people with the same stage can differ in tumour tests, kidneys, age and daily life. Each of these can change the regimen. A plan that differs from a relative's usually means it was fitted to you.
"Tablets are weaker than a drip."
Capecitabine tablets turn into the same active drug as fluorouracil inside the body. In trials, CAPOX and FOLFOX worked about equally well after surgery. What matters is taking every tablet as prescribed and reporting side effects early.
"Adding a targeted drug after surgery gives extra protection."
Large trials tested exactly this and found no benefit after surgery for stage II or III. Targeted drugs help in advanced cancer, where tumour tests point to them. After surgery they add cost and side effects without lowering the risk of a return.
"If oxaliplatin is stopped early, the treatment has failed."
Oxaliplatin is often reduced or stopped when numbness or tingling in the hands and feet builds up, to protect you from lasting nerve damage. The other drug usually continues. Stopping it for this reason is planned care, and it is common.
Being straight with you
What this page cannot tell you
It cannot tell you which regimen is right for you. That needs your full pathology report, your tumour test results, your blood tests and a conversation about your life. The CION tumour board reviews these together, and your medical oncologist explains the reasoning in plain words.
Where the evidence is less certain
For people in their seventies and older, how much oxaliplatin adds after surgery is less clear, so the choice leans on fitness and preference. For stage II without high-risk features, many people need no chemotherapy at all. Your oncologist should tell you when a choice is a close call.
Who this does not apply to
If the cancer is in the rectum, chemotherapy is often combined with radiation and planned differently, and the rectal cancer pages cover that. Stage I colon cancer is usually treated with surgery alone. This page also does not cover chemotherapy given into the abdomen during HIPEC.
If a regimen has been recommended and you do not understand why, ask for the reasoning in writing, or call the helpline for a second opinion.Questions we are asked
Common questions about choosing a colon cancer regimen
Is FOLFOX or CAPOX better after colon cancer surgery?
Neither is better for everyone, and in trials they worked about equally well. CAPOX means tablets at home and fewer visits. FOLFOX means a pump and more day-unit visits, with more room to adjust doses. For lower-risk stage III, a shorter course of CAPOX is a common choice.
Why was I not offered oxaliplatin?
Usually because the added benefit for you is small, as in some stage II cancers and in many older people, or because numbness, kidney problems or other illnesses make it riskier. Ask your oncologist which reason applied. A single-drug course is a recognised choice.
Can the regimen change once treatment starts?
Yes. Doses are often lowered, rounds delayed or oxaliplatin dropped when side effects build up. Switching between FOLFOX and CAPOX is also possible if travel, the pump or the tablets become a problem. Changes are planned with your oncologist, never made on your own.
Why does MSI status matter for chemotherapy?
MSI-high cancers behave differently. In stage II they generally gain nothing from a single chemotherapy drug, and many people need no chemotherapy at all. In advanced cancer, MSI-high tumours often respond well to immunotherapy, which may be offered first instead of chemotherapy.
Is irinotecan used after surgery?
No. Trials of irinotecan-based chemotherapy after colon cancer surgery did not show a benefit, so FOLFIRI is kept for advanced disease. If irinotecan is planned, some doctors test a gene called UGT1A1 first, because it affects how well the body clears the drug.
Can I have chemotherapy closer to home?
Often, especially with CAPOX, where much of the treatment is tablets. Drip days still need a day unit with oncology staff, and blood tests are needed before each round. Ask which CION centre is nearest to you, and whether blood tests can be done locally to cut travel.
Does the choice of regimen change the cost?
Yes. Oxaliplatin, a pump, a port, the number of day-unit visits and the length of the course all change the bill. Ask for a written estimate for the full course before starting, and check exactly what your insurance policy or scheme package covers.
Should I get a second opinion on the regimen?
If the reasoning has not been explained clearly, yes, and asking early keeps any delay short. Bring your pathology report, tumour test results and recent blood tests. The CION helpline can arrange a review with a medical oncologist at any CION centre.
Your Specialists
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Colorectal Cancer Chemotherapy
- American Cancer Society — Colon Cancer Treatment, by Stage
- NICE — Colorectal cancer
- ESMO — Colorectal Cancer: A Guide for Patients
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Three months or six months of adjuvant chemotherapy?The next decision once the regimen is chosenWhy tumour side changes the drug choiceWhy left and right colon cancers get different drugsWhen targeted therapy is addedWhich tumour results bring a targeted drug into the planCost of adjuvant chemotherapy for colon cancerWhat a full course costs in Hyderabad
Talk to us
Not sure why this regimen was chosen for you?
Share your pathology report and tumour test results, and a medical oncologist will explain the reasoning behind the plan in plain words. If a different regimen would suit you better, they will say so. One helpline serves every CION centre.